Diabetic Retinopathy ( second part ) بالانجليزية

Diabetic retinopathy (DR) is commonly linked to symptoms such as blurry vision, light sensitivity, seeing halos around lights, flashes, floaters, difficulty reading, poor night vision, and sudden vision loss. Various eye exams, including funduscopy, optical coherence tomography, and fluorescein angiography, can help in diagnosing DR. It is crucial for patients diagnosed with DR to adhere to their treatment plan to prevent complications such as vitreous haemorrhage, retinal detachment, glaucoma, and ultimately, blindness, which can severely impact their quality of life.

Various treatment options are available for diabetic retinopathy, such as laser therapy, injections, and surgery. The goal of treatment is to prevent blindness, improve vision, and maintain stable eyesight. However, managing blood sugar levels is crucial in effectively treating the condition.

In the initial three phases of diabetic retinopathy, no intervention is necessary unless the macula is impacted. The final stage, proliferative retinopathy, can be treated through either focal laser treatment or scatter laser treatment. Focal laser treatment can help prevent leakage of fluids and blood in the eye, while scatter laser treatment can reduce the size of abnormal blood vessels in the retina.

Furthermore, intravitreal injections involve injecting medication directly into the gel-like vitreous of the eye. This helps reduce the growth of new blood vessels in diabetic retinopathy. These injections can be used alone or in conjunction with laser therapy for maculopathy. In situations of significant bleeding, a vitrectomy surgery may be necessary.

Read more: see third part .......................

References

American Academy of Ophthalmology. (2021). Diabetic retinopathy. Retrieved from

               https://www.aao.org/topic-detail/diabetic-retinopathy-middle-east.

American Optometric Association. (2017). Diabetic retinopathy. Retrieved from https://www.aoa.org.

Hooper, P., Boucher, M., Cruess, A., Dawson, K.G., Delpero, W., Greve, M., Kozousek, V., Lam, W.,

        & Maberley, D. (2012).Canadian Ophthalmological society evidence-based clinical practice

         guidelines for the management of diabetic retinopathy. Can J Ophthalmol, 47 (1): 3-11.

Kumar, K.B., Bhowmik, D., Harish,G., Duraivel,S., & kumar, B.P. (2012). Diabetic retinopathy-

              symptoms, causes, risk factors and treatment. Pharma Innovation Journal,1(8):7-13. 

National Eye Institute. (2019). Diabetic retinopathy. Retrieved 

              from https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-

              diseases/diabeticretinopathy.

Rohilla, A., Kumar, R., Rohilla, S., & Kushnoor A. (2012). Diabetic retinopathy: origin and

            complications. European Journal of Experimental Biology, 2 (1): 88-94.